FORM 8-K Current Report Pursuant to Section 13
Post# of 72440
Posted On: 03/31/2016 8:33:52 AM
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Departure of Chief Medical Officer
Effective March 31, 2016, Daniel Jorgensen MD, a non-executive officer, will no longer serve as the Chief Medical Officer of Cellceutix Corporation. Dr. Jorgensen's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Cellceutix CMO bids adieu
Mar 31 2016, 06:49 ET | About: Cellceutix Corp. (CTIX) | By: Douglas W. House, SA News Editor
On SA email blast. That's it.
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Departure of Chief Medical Officer
Effective March 31, 2016, Daniel Jorgensen MD, a non-executive officer, will no longer serve as the Chief Medical Officer of Cellceutix Corporation. Dr. Jorgensen's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Cellceutix CMO bids adieu
Mar 31 2016, 06:49 ET | About: Cellceutix Corp. (CTIX) | By: Douglas W. House, SA News Editor
On SA email blast. That's it.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼